News

Neutrophils, one of the immune system warriors that were thought to be all the same, turn out to be diverse. Unfortunately, ...
Neutrophils, one of the immune system warriors that were thought to be all the same, turn out to be diverse. Unfortunately, ...
In rheumatology, there is always more to learn — even when it comes to the most well-trod topics and commonly researched ...
As global stock markets experience significant fluctuations in April 2025 due to world trade conflicts, more investors are ...
Physicians and patient advocates are sounding the alarm after the NIH abruptly withdrew a grant renewal application for the ...
The FDA has approved Uplizna (inebilizumab-cdon) for the treatment of immunoglobulin G4-related disease in adult patients.
Nika Beamon set out on a journey, and 26 doctors, 37 procedures and more than 17 years later, a rheumatologist finally ...
With autoimmune pancreatitis linked to a higher cancer risk, doctors must use comprehensive imaging to avoid unnecessary ...
IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition marked by the accumulation of IgG4-positive plasma ...
Last week, the FDA signed off on the use of Uplizna for IgG4-related disease, a condition that involves the infiltration of B cells into various organs, causing widespread damage. In this indication, ...
The disease, which is characterized by high blood glucose (sugar), or hyperglycemia, usually results from a combination of unhealthy lifestyle habits, obesity, environmental factors, and genetics.